Aug 06, 2020 7:00am EDT Recro to Report Second Quarter 2020 Financial Results and Host Conference Call and Webcast on August 10, 2020
Jun 11, 2020 10:00am EDT Recro Highlights Manufacturing Readiness For Essential Drugs and Medical Supplies
May 11, 2020 7:00am EDT Recro Reports First Quarter 2020 Financial Results and Provides Update on COVID-19 Response and Impact
May 08, 2020 7:00am EDT Recro to Report First Quarter 2020 Financial Results and Host Conference Call and Webcast on May 11, 2020
May 01, 2020 4:05pm EDT Recro Announces Change in Location of its 2020 Annual Meeting of Shareholders to its Corporate Headquarters
Mar 02, 2020 7:00am EST Recro to Report Year End 2019 Financial Results and Host Conference Call and Webcast on March 4, 2020
Nov 21, 2019 4:30pm EST Recro Completes Separation of Baudax Bio and Becomes a Dedicated Contract Development and Manufacturing Organization
Nov 21, 2019 7:00am EST Baudax Bio™ Launches as a New Pharmaceutical Company Aimed at Advancing Promising, Non-Opioid Analgesic Therapies
Nov 13, 2019 7:00am EST Recro Pharma Announces Effectiveness of Baudax Bio Form 10 Registration Statement